iflix
GlaxoSmithKline ingredion favored.. Kramer Capital CIO

GlaxoSmithKline ingredion favored.. Kramer Capital CIO

  • TV-G
  • 2019
  • 3mins
Hilary Kramer chief investment officer at Kramer Capital Research talks about U.S. stocks and corporate earnings. She speaks with Shery Ahn and Paul Allen on Bloomberg Daybreak: Australia.